Insight Molecular Diagnos...

NASDAQ: IMDX · Real-Time Price · USD
2.41
0.01 (0.42%)
At close: Aug 15, 2025, 2:51 PM

Insight Molecular Diagnostics Balance Sheet Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
8.64M 9.43M 19.99M 35.6M
Short-Term Investments
n/a n/a 433K 904K
Long-Term Investments
1.7M n/a 1.7M 1.7M
Other Long-Term Assets
4.26M 2.16M 2.07M 1.96M
Receivables
1.61M 484K 2.01M 1.44M
Inventory
410K n/a 2.12M 304K
Other Current Assets
1.1M 782K 3.1M 2.95M
Total Current Assets
11.76M 10.7M 25.54M 39.14M
Property-Plant & Equipment
2.76M 5.44M 10.85M 8.53M
Goodwill & Intangibles
14.61M 56.59M 61.63M 109.93M
Total Long-Term Assets
23.32M 64.19M 74.56M 120.42M
Total Assets
35.08M 74.89M 100.09M 159.56M
Account Payables
2.28M 953K 1.25M 1.81M
Deferred Revenue
n/a n/a n/a n/a
Short-Term Debt
1.29M n/a 815K 2.13M
Other Current Liabilities
872K 4.01M 7.45M 6.53M
Total Current Liabilities
7.28M 7.19M 12.11M 14.12M
Long-Term Debt
n/a n/a n/a n/a
Other Long-Term Liabilities
37.71M 39.9M 50.96M 76.68M
Total Long-Term Liabilities
40.08M 42.1M 53.69M 80.23M
Total Liabilities
47.35M 49.3M 65.8M 94.35M
Total Debt
3.66M 2.87M 3.54M 5.68M
Common Stock
338.24M 310.3M 294.93M 252.95M
Retained Earnings
-350.54M -289.88M -260.68M -187.77M
Comprehensive Income
21K 49K 39K 37K
Shareholders Equity
-12.27M 25.59M 34.29M 65.22M
Total Investments
1.7M 1.7M 433K 904K